DEXCOM, INC. Debt and Equity Securities, Unrealized Gain (Loss)
DEXCOM, INC. (DXCM) reported Debt and Equity Securities, Unrealized Gain (Loss) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss · last filed 2025-02-18
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for the quarter ending 2019-12-31 was $0.00.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for the quarter ending 2018-12-31 was -$4.80M.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for the quarter ending 2018-09-30 was $20.80M.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for fiscal 2024 was $0.00.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for fiscal 2023 was $0.00.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for fiscal 2022 was $0.00.
- DEXCOM, INC. debt and equity securities, unrealized gain (loss) for fiscal 2021 was $0.00.
| Period end | Debt and Equity Securities, Unrealized Gain (Loss) 3 month | Debt and Equity Securities, Unrealized Gain (Loss) 6 month | Debt and Equity Securities, Unrealized Gain (Loss) 9 month | Debt and Equity Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $0.00 10-K · filed 2021-02-11 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | ||
| 2018-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $16.00M derived: sum of 2 quarters · filed 2021-02-11 | $36.00M 10-K · filed 2021-02-11 | |
| 2018-09-30 | $20.80M 10-Q · filed 2019-11-06 | $40.80M 10-Q · filed 2019-11-06 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-13 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |